Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
Phase 4
Not yet recruiting
Conditions
Ordinary Disorder Needed Planned Surgery and General Anesthesia
Interventions
Drug: Tegoprazan
Drug: Famotidine
Drug: Placebo
Subscribe
First Posted Date
2024-12-19
Last Posted Date
2024-12-19
Lead Sponsor
Kim, Young Sung
Target Recruit Count
174
Registration Number
NCT06743243
Locations
🇰🇷
Korea University Medical Center, Guro Hospital, Seoul, Korea, Republic of
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy